Rosuvastatin - NDC Database (Page 4)
68382-627 Jan 16, 2020
Rosuvastatin 5 mg Oral Tablet, Film Coated by Zydus Pharmaceuticals (Usa) Inc.
Rosuvastatin 5 mg Oral Tablet, Film Coated by Zydus Pharmaceuticals (Usa) Inc.
68382-628 Jan 16, 2020
Rosuvastatin 10 mg Oral Tablet, Film Coated by Zydus Pharmaceuticals (Usa) Inc.
Rosuvastatin 10 mg Oral Tablet, Film Coated by Zydus Pharmaceuticals (Usa) Inc.
68382-629 Jan 16, 2020
Rosuvastatin 20 mg Oral Tablet, Film Coated by Zydus Pharmaceuticals (Usa) Inc.
Rosuvastatin 20 mg Oral Tablet, Film Coated by Zydus Pharmaceuticals (Usa) Inc.
68382-630 Jan 16, 2020
Rosuvastatin 40 mg Oral Tablet, Film Coated by Zydus Pharmaceuticals (Usa) Inc.
Rosuvastatin 40 mg Oral Tablet, Film Coated by Zydus Pharmaceuticals (Usa) Inc.
68788-7673 Feb 28, 2020
Rosuvastatin 10 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals, Inc.
Rosuvastatin 10 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals, Inc.
68788-7971 Jul 21, 2021
Rosuvastatin 5 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals Inc.
Rosuvastatin 5 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals Inc.
68788-8533 Oct 05, 2023
Rosuvastatin 20 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals Inc.
Rosuvastatin 20 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals Inc.
68788-8649 May 03, 2024
Rosuvastatin 40 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals Inc.
Rosuvastatin 40 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals Inc.
68788-8698 Jun 14, 2024
Rosuvastatin 20 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals Inc.
Rosuvastatin 20 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.